CAV1 and cancer: Along similar lines, a recent study showed that understanding the internalization mechanisms through Cav-1-dependent pathways was crucial for optimizing the delivery of the human papillomavirus HPV16E7 affibody that enters cells to target intracellular proteins and neutralizes the HPV16 E7 oncoprotein, potentially stopping the progression of cancer at an early stage [112].